Beijing Chongde Yingsheng Investment Management is a Beijing venture-capital fund manager focused on innovative medicines, medical devices, research and development services and biotechnology. It manages Beinao I, a specialist neuroscience fund investing in next-generation diagnostics, treatments, medical equipment, consumables and drugs for brain disorders. The firm also manages the separate, older Beijing Chongde Yingsheng Venture Capital vehicle.
Founded
2015
Type
Venture capital
Funds1
北脑一期（北京）股权投资中心（有限合伙）CN¥90M
Beinao I is a specialist neuroscience venture fund managed by Beijing Chongde Yingsheng Investment Management. It invests in next-generation diagnostic and treatment equipment, consumables and medicines for brain disorders, with a priority for early-stage companies in Beijing’s Changping district. Its partners had paid in the full CNY90m corpus by the September 2026 issuer announcement.
Team
Operations and support
Liu YuanyuanHead of Compliance and Risk Control; Information Reporting Officer